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Abstract KCNQ2 and KCNQ3 subunits belong to the six
transmembrane domain K+ channel family and loss of function
mutations are associated with benign familial neonatal convul-
sions. KCNE2 (MirP1) is a single transmembrane domain
subunit first described to be a modulator of the HERG potassium
channel in the heart. Here, we show that KCNE2 is present in
brain, in areas which also express KCNQ2 and KCNQ3
channels. We demonstrate that KCNE2 associates with KCNQ2
and/or KCNQ3 subunits. In transiently transfected COS cells,
KCNE2 expression produces an acceleration of deactivation
kinetics of KCNQ2 and of the KCNQ2^KCNQ3 complex.
Effects of two previously identified arrhythmogenic mutations of
KCNE2 have also been analyzed. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The KCNQ family of potassium channels belonging to the
six transmembrane domain group, was recently described.
This family comprises ¢ve members, called KCNQ1
(KvLQT1) to KCNQ5.
KCNQ1 is highly expressed in heart [1]. It is associated with
the regulatory protein KCNE1 (IsK) to produce the cardiac
slow delayed recti¢er (IKs) current [2,3]. KCNQ2 [4,5] and
KCNQ3 [6] are expressed in the same brain areas such as
hippocampus, neocortex and cerebellum [5,7,8]. KCNQ4 is
strongly expressed in the inner ear [9,10]. KCNQ5 is found
in brain and sympathetic ganglia [11,12]. Heteromultimeric
associations of KCNQ2 with KCNQ3 and KCNQ4, and
KCNQ3 with KCNQ5 are thought to correspond to the M-
current, a muscarinic sensitive voltage- and time-dependent
potassium current expressed in a variety of neuronal cell types
[9,11^13].
Except for KCNQ5, all of the known KCNQ channels de-
scribed to date are associated with inherited diseases. KCNQ1
is responsible for inherited cardiac long QT syndromes [1,14^
16]. KCNQ2 and KCNQ3 are both linked to benign familial
neonatal convulsions (BFNC) [4,6,7]. KCNQ4 is linked to a
non-syndromic dominant deafness form, DFNA2 [9].
Recently, KCNE2 (MirP1) was described to be the partner
of the HERG potassium channel in the heart where the com-
bination could underlie the native cardiac Ikr current [17]. We
analyzed the KCNE2 tissue distribution using a human
cDNA panel, and we found that KCNE2 substantially ex-
pressed in human brain. The localization of KCNE2 RNAs
using in situ hybridization analysis shows that it is expressed
in the same brain regions that also express KCNQ2 and
KCNQ3 [5]. This observation evidently led to the hypothesis
that KCNE2 might modulate KCNQ2 and KCNQ3 channel
activities. Immunoprecipitation experiments have indeed
shown that KCNE2 is associated with both KCNQ2 and
KCNQ3 subunits. Moreover KCNE2 has been shown to reg-
ulate the KCNQ2 and/or KCNQ3 channel activities by mod-
ulating their deactivation kinetics. The e¡ects of the native
KCNE2 subunit are changed when it is substituted by
KCNE2 mutants which are described to be associated with
long QT syndrome and ventricular ¢brillation [17].
2. Materials and methods
2.1. Ampli¢cation
KCNE2 (GenBank clone, accession number AP000052) was ampli-
¢ed from human brain cDNAs using the polymerase chain reaction
(PCR) performed with primers KCNE2-M AGCGAATTCGAAG-
CATGTCTACTTTATCC and KCNE2-T CTTTTGTCGACTAT-
CAGGGGGACATTT. The ampli¢cation pro¢le was 94‡C, 1 min,
55‡C, 1 min, 72‡C, 1 min, 35 cycles. PCR products were subcloned
into pCI-IRES-CD8 mammalian expression vector and checked by
sequencing.
2.2. Tissue distribution
A panel of human tissue cDNAs (Clontech) was used as a template
for PCR distribution analysis of the KCNE2 and KCNE1 (IsK). PCR
primers used were KCNE2-M and KCNE2-T, IsK-A, TGCAG-
CAGTGGAACCTTAAT and IsK-B, TAGCCAGTGGTGGGGTT-
CA for KCNE2 and KCNE1. The PCR pro¢le was: 94‡C, 3 min,
94‡C, 40 s, 55‡C, 1 min, 72‡C, 1 min 30 s, 28 cycles.
PCR products were electrophoresed and blotted onto Hybond-N
membranes (Amersham), and probed with KCNE2 full length or with
IsK-C, GTCGTGCTATGTCGTTGAAAATCT.
2.3. In situ hybridization
Antisense and sense RNA probes were generated from linearized
plasmids containing the full length KCNE2 cDNA. Tissue prepara-
tion and hybridization were performed as described in [18]. The hy-
bridization temperature was 50‡C. Specimens were exposed to Amer-
sham L-max Hyper¢lm for 7 days.
Selected slides were subsequently dipped in photographic emulsion
(LM-1, Amersham), incubated for 4 weeks, and then developed in
Kodak D-19. Rat brain structures were identi¢ed according to Pax-
inos and Watson [19].
2.4. Coimmunoprecipitation
c-myc-Tagged KCNE2 was prepared by PCR using KCNE2-M and
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KCNE2-c-myc oligonucleotides GATATCACAGATCCTCTTCTG-
AGATGAGTTTTTGTTCGGGGGACATTTTGAACCCAGC.
Proteins were in vitro translated (TNT system, Promega) with 35S-
methionine (ICN) as a radioactive marker, starting with 2 Wg of each
plasmid (pCI-KCNE2-c-myc, pCI-KCNQ2, pCI-KCNQ3 and pCI-
Kv4.2) per 50 Wl ¢nal reaction. Proteins were then ¢ve fold diluted
with a bu¡er containing 150 mM NaCl, 50 mM Tris^HCl pH 7.4,
1 mM iodoacetamide, 1U mixture of protease inhibitors (Roche) and
1.5% Tween 20.
An equal volume of each in vitro translation was mixed and incu-
bated 4 h on ice and then immunoprecipitated with an anti-c-myc
monoclonal antibody (9E10 Santa Cruz Biotechnology) immobilized
on protein-A^Sepharose gel (Amersham Pharmacia). Immunoprecipi-
tates were analyzed on 12% SDS^PAGE.
2.5. Electrophysiological measurements in transfected COS cells
COS-7 cells were grown and transfected as described in [5] with 1 Wg
or 0.5 Wg (in the coexpression experiments) of pCI-IRES-CD8-
KCNE2 and pCI-KCNQ2 or pCI-KCNQ3 per dish. Cells were tested
in electrophysiological experiments 48 h post transfection.
Electrophysiological recordings were carried out at 22 þ 2‡C in the
whole-cell con¢guration of the patch-clamp technique. The intracel-
lular pipette ¢lling solution contained 150 mM KCl, 0.5 mM MgCl2,
5 mM EGTA and 10 mM HEPES^KOH at pH 7.4 and the standard
extracellular solution contained 150 mM NaCl, 5 mM KCl, 1 mM
CaCl2, 3 mM MgCl2, 5 mM glucose and 10 mM HEPES^NaOH at
pH 7.4.
Data analysis allowed the presentation of values as the mean þ
S.E.M. for the density (pA/pF), the voltage dependence of activation
(V0:5 in mV, and slope factor), and activation and deactivation ki-
netics (dact and ddeac in ms) of the currents.
3. Results
3.1. KCNE2^KCNE1 sequence comparison
KCNE2 presents 51.2% of overall conservative homology
with KCNE1 with a highly conserved region, amino acids 50^
100, which shares 72% homology (Fig. 1A). The two potential
N-glycosylation sites identi¢ed in the KCNE1 sequence are
also present in the KCNE2 sequence but a deletion of 11
amino acids at position 102 results in a loss of one of the
two phosphorylation sites for protein kinase C identi¢ed in
the KCNE1 sequence (Fig. 1A).
3.2. Tissue distribution of human KCNE2
The tissue distribution of human KCNE2 mRNAs indicates
that KCNE2 is more widely distributed than KCNE1 (Fig.
1B). KCNE2 expression is highest in brain, heart, skeletal
muscle, pancreas, placenta, kidney, colon and thymus. A
small but signi¢cant expression is found in liver, ovary, testis,
prostate, small intestine and leukocytes. KCNE2 expression is
very low, nearly undetectable, in lung and spleen.
3.3. Localization of KCNE2 in the rat brain by in situ
hybridization
Hybridization with a KCNE2 probe reveals a very intense
signal in the 4th and lateral ventricles (Fig. 2A^C). This in-
tense labelling is not related to a neuronal expression (Fig.
2F). In addition, a neuronal expression is observed in cerebel-
lum (Fig. 2A), neocortex, piriform cortex (Fig. 2B), the hippo-
campal formation, thalamus, hypothalamus, zona incerta, and
various unidenti¢ed brainstem nuclei (Fig. 2C).
In cerebellum, both granule and Purkinje neurons are la-
belled (Fig. 2D). A moderate to strong signal is seen in all
layers of the neocortex (Fig. 2E). Within the hippocampus,
transcripts are abundant in both pyramidal neurons through-
out the Ammon’s horn and in dentate gyrus granule neurons
(Fig. 2G).
No signal was seen when sections were hybridized with the
corresponding sense riboprobe (data not shown).
3.4. Immunoprecipitation
First, we checked that KCNE2-c-myc displayed the same
Fig. 1. Sequence and tissue distribution comparisons between KCNE1 and KCNE2. A: Sequence comparison between KCNE1 and KCNE2
proteins. Alignment of human KCNE1 and human KCNE2 protein sequences. Identical and conservative residues are boxed black and gray,
respectively. Gaps are introduced to display the best alignment. The transmembrane domain is underlined by a bar. Filled circles indicate N-
glycosylation sites and ¢lled squares, phosphorylation sites of protein kinase C. B: Tissue distribution comparison between KCNE1 RNA and
KCNE2 RNA.
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ability as the native KCNE2 to modulate KCNQ channel
activities (data not shown).
When in vitro translated KCNE2-c-myc is mixed either
with in vitro translated KCNQ2 or KCNQ3, the c-myc mono-
clonal antibody immunoprecipitates both KCNE2 and
KCNQ channel subunits (Fig. 4, lanes 2 and 3). No
KCNQ2 immunoprecipitation was obtained in the absence
of KCNE2 in the mixture (Fig. 3, lane 5). Under the same
experimental conditions, the Kv4.2 channel does not copreci-
pitate with KCNE2-c-myc (Fig. 3, lane 4).
3.5. E¡ects of the KCNE2 subunit on the electrophysiological
properties of KCNQ2 or KCNQ3 currents
The whole-cell voltage clamp technique was used for cur-
rent recordings in transiently transfected COS cells. In our
expression conditions both KCNQ2 and KCNQ3 are able
to produce active K currents. The combination
KCNQ2+KCNQ3 results in the expression of a new current
that can be discriminated from each independent current by
its voltage dependence of activation and by its time constant
of activation (Table 1).
Fig. 2. In situ hybridization of KCNE2. Localization of KCNE2 mRNA in the adult rat brain. A^C: Autoradiograms of rat coronal brain sec-
tions after in situ hybridization with the KCNE2 riboprobe. D^G: high power images of photomicrographic emulsion dipped slices at level of
the (D) cerebellar granule layer, E: neocortex, F: 4th ventricle and G: hippocampus. CA1: pyramidal cell layer, Cx: neocortex, DG: dentate
gyrus, Gr: cerebellar granule cell layer, hip: hippocampus, Hy: hypothalamus, LV: lateral ventricle, Pir: piriform cortex, Th: thalamus.
Table 1
Electrophysiological parameters of KCNQ2, KCNQ3 currents and heteromultimers associated or not with the KCNE2 protein or its mutants
Channel type Current Density
(pA/pF)
Activation curve Time constant of
activation (ms)
Time constant of
deactivation (ms)
V0:5 (mV) Slope (mV)
KCNQ2 12.1 þ 1.4 (16) 326.1 þ 1.3 (14) 13.2 þ 0.8 (14) 156.7 þ 9 (14) 236 þ 9.9 (12)
KCNQ2+KCNE2 15.2 þ 2.8 (7) 329 þ 1.8 (12) 13.3 þ 1.1 (12) 110.8 þ 11.3 (10)***(a) 156 þ 6.1 (12)***(a)
KCNQ2+KCNE2-Q9E 10.8 þ 1.7 (10) 330.7 þ 1.6 (11) 11.6 þ 0.8 (11) 90 þ 4.2 (10) 190 þ 5.5 (10)***(b)
KCNQ2+KCNE2-I57T 16.8 þ 5.9 (7) 325.6 þ 3.8 (7) 13.6 þ 1.6 (7) 117 þ 12 (7) 227 þ 17.3 (7)***(b)
KCNQ3 11.2 þ 2.8 (13) 339 þ 1.4 (9) 7.9 þ 1.3 (9) 60.6 þ 4.9 (9) 178 þ 25 (6)
KCNQ3+KCNE2 7.8 þ 3 (6) 332.7 þ 3.2 (6) 5.9 þ 2 (6) 47.3 þ 12 (6) 255 þ 70 (5)
KCNQ2+KCNQ3 13.6 þ 1.2 (18) 330.6 þ 0.9 (21) 13.9 þ 0.7 (21) 134.3 þ 5.7 (23) 180.2 þ 8.3 (20)
KCNQ2+KCNQ3+
KCNE2
18 þ 2.6 (13) 325.6 þ 1.4 (17)***(c) 13.4 þ 0.6 (17) 99.5 þ 4.6 (17)***(c) 103 þ 5.4 (15)***(c)
KCNQ2+KCNQ3+
KCNE2-Q9E
16.2 þ 2.1 (10) 323 þ 1.7 (11) 12.1 þ 0.7 (11) 108.4 þ 9.4 (10) 117.4 þ 8.7 (7)
KCNQ2+KCNQ3+
KCNE2-I57T
21.6 þ 3.3 (11) 325.6 þ 1.7 (10) 18.6 þ 1.8 (10)***(d) 68 þ 6 (9)***(d) 118 þ 6 (9)
Values between brackets indicate the number of cells tested.
Statistically signi¢cant di¡erences were assessed by mean of a Student’s t-test, with values obtained from (a) KCNQ2, (b) KCNQ2+KCNE2,
(c) KCNQ2+KCNQ3 and (d) KCNQ2+KCNQ3+KCNE2 (***, P6 0.005).
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The interaction of the KCNE2 subunit with the KCNQ2
channel subunit results in an acceleration of the deactivation
kinetics of the current. Time constants of deactivation at 340
mV are decreased from ddeac = 236 þ 9.9 ms (n = 12) to
156 þ 6.1 ms (n = 12) for KCNQ2 and KCNQ2+KCNE2 re-
spectively (Fig. 4A,C). The activation kinetics are also accel-
erated although in a lesser extent, by the presence of the
KCNE2 subunit. At +30 mV, dact = 156.7 þ 9 ms (n = 14) and
110.8 þ 11.3 ms (n = 10) for KCNQ2 and KCNQ2+KCNE2
channels, respectively.
The KCNE2 subunit does not alter signi¢cantly the voltage
dependence of activation of the KCNQ2 current recorded in
COS cells (Table 1).
The electrophysiological properties of the KCNQ3 channel
were not signi¢cantly altered by the interaction with the
KCNE2 subunit (Table 1).
3.6. KCNE2 associates with heteromultimers
KCNQ2+KCNQ3
Representative traces recorded in cells expressing
KCNQ2+KCNQ3 in the absence or the presence of KCNE2
are shown in Fig. 4B.
As observed with KCNQ2 alone, coexpression of KCNE2
with KCNQ2+KCNQ3 results in an acceleration of both the
activation and deactivation processes. The time constant of
activation at +30 mV is dact = 99.5 þ 4.6 ms in the presence
of KCNE2 versus 134.3 þ 5.7 ms in its absence (n = 40,
P6 0.005), and the time constant of deactivation at 340
mV changes from 180.2 þ 8.3 ms to 103 þ 5.4 ms (n = 35,
P6 0.005) (Fig. 4D and Table 1). While KCNE2 coexpression
shifted the voltage dependence of activation to more negative
values, it shifted the V0:5 of KCNQ2+KCNQ3 activation by
about 5 mV towards positive values (Table 1). Coexpression
of the KCNE2 subunit did not a¡ect signi¢cantly the mean
current density (Fig. 4E,F and Table 1).
3.7. E¡ects of KCNE2 arrhythmogenic mutations
KCNE2 mutations have been reported to be linked to car-
diac arrhythmia [17]. We have introduced two of them, I57T
and Q9E, in the KCNE2 sequence to analyze their e¡ects on
KCNQ2 and KCNQ2+KCNQ3 currents. It appears that each
mutation has speci¢c e¡ects on the biophysical properties of
these currents (see Table 1). As a general rule these mutations
tend to reduce the kinetic e¡ects of the wild type KCNE2,
excepted for KCNE2-I57T which accelerates the current acti-
vation of KCNQ2+KCNQ3 channels (Table 1).
4. Discussion
KCNE2 shows a strong overall conservative homology with
KCNE1. A notable di¡erence between these two proteins, is a
deletion of 11 amino acids at position 102 of KCNE2 which
Fig. 3. KCNE2 immunoprecipitation. 12% SDS^PAGE analysis of
in vitro translations immunoprecipitated with a c-myc monoclonal
antibody. KCNE2-c-myc alone (lane 1), KCNE2-c-myc+KCNQ2
(lane 2), KCNE2-c-myc+KCNQ3 (lane 3), KCNE2-c-myc+Kv4.2
(lane 4), KCNQ2 alone (lane 5).
Fig. 4. KCNE2 subunit associates with KCNQ2 and
KCNQ2+KCNQ3 channels in COS cells. Currents were recorded in
transfected COS cells in the whole-cell con¢guration. Current den-
sities were calculated for each channel combination, only cells ex-
pressing currents larger than 5 pA/pF were considered in this calcu-
lation. A and B: Representative traces for (A) KCNQ2 and
KCNQ2+KCNE2 currents, and (B) KCNQ2+KCNQ3, and
KCNQ2+KCNQ3+KCNE2 currents. Traces were elicited by 2 s
voltage steps from a holding potential of 380 mV over the range of
360^+60 mV in 10 mV increment. C and D: Time constants of de-
activation (ddeac in ms) are calculated from tail currents elicited
from 3120 to 340 mV in 10 mV increment after a test pulse to
+30 mV. C: KCNQ2 (¢lled circle), KCNQ2+KCNE2 (open circle).
D: KCNQ2+KCNQ3 (¢lled circle) and KCNQ2+KCNQ3+KCNE2
(open circle). E and F: Histograms of the percentage of cells pro-
ducing indicated current densities for (E) KCNQ2+KCNQ3 and (F)
KCNQ2+KCNQ3+KCNE2. The current density (pA/pF) was calcu-
lated for each recorded cell in relation with the capacitance and the
peak current amplitude at +30 mV. Averaged current densities were
compared in each combination with Student’s t-test. Mean values
are not signi¢cantly modi¢ed with the KCNE2 expression with cur-
rent densities of 11.82 þ 1.04 for KCNQ2+KCNQ3 (n = 44), and of
11.76 þ 1.55 for KCNQ2+KCNQ3+KCNE2 (n = 35), P = 0.97.
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leads to a loss of a phosphorylation site for protein kinase C,
described to be important for the regulation of KCNE1 ac-
tivity [20,21]. Nevertheless, the sequence comparison clearly
indicates that KCNE2 is a member of the KCNE family
and thus could potentially interact with a KCNQ potassium
channel like KCNE1 does [2,3,22]. However, KCNE1 and
KCNE2 present important di¡erences in their tissue distribu-
tion. The expression of KCNE2 in the brain led us to analyze
the localization of KCNE2 in the central nervous system. The
overall distribution of the KCNE2 mRNA in the rat and
mouse central nervous systems was similar to that described
earlier for KCNQ2 and KCNQ3 in mouse brain [5]. Hetero-
multimers of these two K channel subunits are thought to
have an important role in the central nervous system where
they are believed to form the M-type K channel [9,13] and
are both linked to a familial form of newborn epilepsy [4,6,7].
The apparent colocalization of KCNQ2, KCNQ3 and
KCNE2 suggested that KCNE2 could be a good candidate
as a regulatory subunit of the KCNQ2^KCNQ3 M-type chan-
nel. We present arguments in favor of such a hypothesis.
First, KCNQ2 and KCNQ3 subunits can be speci¢cally coim-
munoprecipitated with KCNE2 under in vitro conditions. Sec-
ond, electrophysiological studies performed in COS cells,
show that the deactivation kinetics of either KCNQ2 or
KCNQ2 associated with KCNQ3 channels are increased by
the coexpression of the KCNE2 subunit. Although these ef-
fects are not as spectacular as those of KCNE1 on KCNQ1,
they are highly signi¢cant (P6 0.005). Moreover, they are
very similar to those reported for KCNE2 modulating e¡ects
on the HERG channel [17].
Missense mutations have been found in the KCNE2 gene
from patients with long QT syndrome, that modulate KCNE2
e¡ects on the HERG channel [17]. We found that KCNE2-
I57T and KCNE2-Q9E mutants partially or totally reversed
the e¡ect of the native KCNE2. This partial or total loss of
KCNE2 function induced by these mutations could indicate
that patients with such mutations can, in addition to the long
QT disease, also present neurological disorders.
All our data including in situ localization and in vitro phys-
ical and functional interactions argue in favor of an associa-
tion between the KCNQ2 and KCNQ3 channels and KCNE2
subunit. Data from literature also support this ¢nding. The
native M-current thought to be formed by the association of
KCNQ2 with KCNQ3, displays deactivation kinetics faster
than those recorded in the heterologous expression experi-
ments [13]. It was reported that the heterologously expressed
KCNQ2+KCNQ3 current had a deactivation time constant of
ddeac = 174 ms, a value very similar to the one found in the
present study (180 ms, Table 1). In the same study [13], the
deactivation time constant of native M-current was evaluated
to d1deac = 103 ms (at 350 mV), a value almost identical to the
d1dea conferred by the association of the KCNE2 subunit to
the KCNQ2+KCNQ3 complex (Table 1). Hence, channels
formed by the association of the three subunits appropriately
recapitulate native M-current.
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